XML 31 R18.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Equity-Based Compensation

In February 2019, the Company's Board of Directors approved the Steven Madden, Ltd. 2019 Incentive Compensation Plan (the “2019 Plan”), under which nonqualified stock options, stock appreciation rights, performance shares, restricted stock, other stock-based awards and performance-based cash awards may be granted to employees, consultants and non-employee directors. The 2019 Plan is the successor to the Company's Amended and Restated 2006 Stock Incentive Plan, as amended (the "2006 Plan"), the term of which expired on April 6, 2019. The Company's stockholders approved the 2019 Plan at the Company's annual meeting of stockholders held on May 24, 2019.

The following table summarizes the number of shares of common stock authorized for use under the 2019 Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the 2019 Plan and the number of shares of common stock available for the grant of stock-based awards under the 2019 Plan:

Common stock authorized
11,000,000

Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled
(212,425
)
Common stock available for grant of stock-based awards as of June 30, 2019
10,787,575




Total equity-based compensation for the three and six months ended June 30, 2019 and 2018 is as follows:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Restricted stock
$
4,938

 
$
4,212

 
$
9,555

 
$
8,138

Stock options
999

 
1,130

 
2,053

 
2,097

Total
$
5,937

 
$
5,342

 
$
11,608

 
$
10,235



Equity-based compensation is included in operating expenses on the Company’s Condensed Consolidated Statements of Income.

Stock Options
 
Cash proceeds and intrinsic values related to total stock options exercised during the three and six months ended June 30, 2019 and 2018 are as follows:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Proceeds from stock options exercised
$
1,077

 
$
9,596

 
$
1,799

 
$
11,115

Intrinsic value of stock options exercised
$
513

 
$
4,902

 
$
842

 
$
5,479


During the three and six months ended June 30, 2019, options to purchase approximately 77,075 shares of common stock with a weighted average exercise price of $33.77 and options to purchase approximately 480,762 shares of common stock with a weighted average exercise price of $27.68 vested, respectively. During the three and six months ended June 30, 2018, options to purchase approximately 79,901 shares of common stock with a weighted average exercise price of $25.94 and options to purchase approximately 566,429 shares of common stock with a weighted average exercise price of $24.62 vested, respectively. As of June 30, 2019, there were unvested options relating to 1,203,775 shares of common stock outstanding with a total of $6,088 of unrecognized compensation cost and an average vesting period of 2.4.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of options granted, which requires several assumptions. The expected term of the options represents the estimated period of time until exercise and is based on the historical experience of similar awards. Expected volatility is based on the historical volatility of the Company’s common stock. The risk free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The dividend yield is based on the Company's annualized dividend per share amount divided by the Company's stock price. The following weighted average assumptions were used for stock options granted during the six months ended June 30, 2019 and 2018:

 
 
2019
 
2018
Volatility
 
32.0% to 33.4%
 
25.1% to 27.2%
Risk free interest rate
 
2.3% to 2.5%
 
2.1% to 2.7%
Expected life in years
 
3.0 to 5.0
 
3.0 to 5.0
Dividend yield
 
1.7%
 
1.7%
Weighted average fair value
 
$8.31
 
$6.45


Activity relating to stock options granted under the Company’s plans and outside the plans during the six months ended June 30, 2019 is as follows:

 
 
Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term
 
Aggregate Intrinsic Value
Outstanding at January 1, 2019
 
2,815,000

 
$
26.03

 
 
 
 

Granted
 
34,000

 
32.46

 
 
 
 

Exercised
 
(80,000
)
 
22.53

 
 
 
 

Outstanding at June 30, 2019
 
2,769,000

 
$
26.21

 
4.3 years
 
$
21,435

Exercisable at June 30, 2019
 
1,565,000

 
$
26.15

 
3.7 years
 
$
12,211



Restricted Stock
 
The following table summarizes restricted stock activity during the six months ended June 30, 2019 and 2018:

 
 
2019
 
2018
 
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
Outstanding at January 1,
 
5,135,000

 
$
18.42

 
5,874,000

 
$
17.37

Granted
 
625,000

 
32.56

 
330,000

 
30.84

Vested
 
(281,000
)
 
26.03

 
(272,000
)
 
23.56

Forfeited
 
(15,000
)
 
26.86

 
(14,000
)
 
25.09

Outstanding at June 30,
 
5,464,000

 
$
19.60

 
5,918,000

 
$
17.81



As of June 30, 2019, the Company had $64,058 of total unrecognized compensation cost related to restricted stock awards granted under the 2019 Plan and the 2006 Plan. This cost is expected to be recognized over a weighted average of 4.3 years. The Company determines the fair value of its restricted stock awards based on the market price of its common stock on the date of grant.

On March 25, 2019, pursuant to an amendment of the employment agreement between the Company and its Creative and Design Chief, Steven Madden, which effected the extension of the term of the agreement for three years through December 31, 2026, Mr. Madden was granted 200,000 restricted shares of the Company's common stock. The restricted stock award will vest in three nearly equal annual installments commencing on December 31, 2024. As of June 30, 2019, Mr. Madden has options unexercised for 675,000 shares of the Company's common stock and 4,134,238 restricted shares of the Company's common stock.